About lonza group ag - LZAGY
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
LZAGY At a Glance
Lonza Group AG
Muenchensteinerstrasse 38
Basel, Basel-Stadt (Basle Town) 4002
| Phone | 41-61-316-81-11 | Revenue | 7.47B | |
| Industry | Biotechnology | Net Income | 727.76M | |
| Sector | Health Technology | 2023 Sales Growth | 14.714% | |
| Fiscal Year-end | 12 / 2024 | Employees | 18,000 | |
| View SEC Filings |
LZAGY Valuation
| P/E Current | 63.514 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 42.518 |
| Price to Sales Ratio | 4.143 |
| Price to Book Ratio | 2.699 |
| Price to Cash Flow Ratio | 19.611 |
| Enterprise Value to EBITDA | 19.969 |
| Enterprise Value to Sales | 4.385 |
| Total Debt to Enterprise Value | 0.114 |
LZAGY Efficiency
| Revenue/Employee | 415,251.699 |
| Income Per Employee | 40,430.938 |
| Receivables Turnover | 4.39 |
| Total Asset Turnover | 0.381 |
LZAGY Liquidity
| Current Ratio | 1.768 |
| Quick Ratio | 1.194 |
| Cash Ratio | 0.604 |
LZAGY Profitability
| Gross Margin | 27.036 |
| Operating Margin | 12.714 |
| Pretax Margin | 11.955 |
| Net Margin | 9.736 |
| Return on Assets | 3.706 |
| Return on Equity | 6.416 |
| Return on Total Capital | 4.867 |
| Return on Invested Capital | 5.172 |
LZAGY Capital Structure
| Total Debt to Total Equity | 33.136 |
| Total Debt to Total Capital | 24.889 |
| Total Debt to Total Assets | 18.334 |
| Long-Term Debt to Equity | 30.734 |
| Long-Term Debt to Total Capital | 23.085 |